Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jun 28;41(2):e2024020.
doi: 10.36141/svdld.v41i2.15156.

Osteoporotic bone fracture risk assessment in Latvian patients with newly diagnosed sarcoidosis

Ieva Ruza  1 , Zane Lucane  2 , Elina Vanaga  2 , Marta Persana  2 , Zane Vitenberga-Verza  3 , Ilze Strumfa  4
Affiliations

Osteoporotic bone fracture risk assessment in Latvian patients with newly diagnosed sarcoidosis

Ieva Ruza et al. Sarcoidosis Vasc Diffuse Lung Dis. .

Abstract

Background and aim: Increased calcitriol synthesis in sarcoid granulomas with subsequent hypercalcaemia and hypercalciuria can affect bone metabolism in patients with sarcoidosis. Multiple factors can increase the fracture risk in patients with sarcoidosis. This study aimed to evaluate a 10-year osteoporotic and a 10-year hip fracture risk and to analyse factors affecting fracture risk for patients with newly diagnosed sarcoidosis compared to an age- and gender-matched control group from a real-world setting.

Methods: The cross-sectional study included 171 patients with a histologically verified diagnosis of sarcoidosis who were hospitalised due to suspected sarcoidosis within two years and an age- and gender-matched control group of 178 hospitalised individuals. QFracture algorithm questions were asked during interviews.

Results: A cohort of 349 subjects was analysed. The median age in the patient group was 40 years (IQR:20), and 60.2% were female. 21.6% of patients with sarcoidosis had at least one comorbidity that could potentially influence the osteoporotic fracture risk. Both the median 10-year osteoporotic fracture risk (0.9% (IQR:2) vs 1.3% (IQR:2.3), p=0.005; U=12394) and a 10-year hip fracture risk (0.1% (IQR:0.3) vs 0.2% (IQR:0.5), p=0.003; U=12368.5) was lower in patients with sarcoidosis compared to control group subjects. As compared to the control group, individuals with sarcoidosis exhibited a lower frequency of both osteoporotic (2.4% vs 11.2%, OR=0.189 (95% CI:0.063-0.566), p=0.003) and low-energy trauma fractures (2.9% vs 11.8%, OR=0.225 (95% CI:0.083-0.612), p=0.003) in personal medical history.

Conclusions: This was the first study to investigate osteoporotic fracture risk and related factors in Latvian patients with newly diagnosed sarcoidosis. Our data show a lower risk of a 10-year osteoporotic and a 10-year hip fracture risk in patients with sarcoidosis compared to age- and gender-matched control group subjects from a real-world setting.

PubMed Disclaimer

Conflict of interest statement

Each author declares that they have no commercial associations that might pose a conflict of interest in connection with the submitted article.

Figures

Figure 1.
Figure 1.
A 10-year osteoporotic and a 10-year hip fracture risk in patients with sarcoidosis and control group: (a) a 10-year osteoporotic fracture risk (n=349) (b) a 10-year hip fracture risk (n=349).
See this image and copyright information in PMC

References

    1. Sève P, Pacheco Y, Durupt F, et al. Sarcoidosis: A Clinical Overview from Symptoms to Diagnosis. Cells. 2021 Mar 31;10(4):766. doi:10.3390/cells10040766. - PMC - PubMed
    1. Spagnolo P, Rossi G, Trisolini R, et al. Pulmonary sarcoidosis. Lancet Respir Med. 2018 May;6(5):389–402. doi:10.1016/S2213-2600(18)30064-X. - PubMed
    1. Markatis E, Afthinos A, Antonakis E, Papanikolaou IC. Cardiac sarcoidosis: diagnosis and management. Rev Cardiovasc Med. 2020 Sep 30;21(3):321–338. doi:10.31083/j.rcm.2020.03.102. - PubMed
    1. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med. 1999 Aug;160(2):736–755. doi:10.1164/ajrccm. - PubMed
    1. Arkema EV, Cozier YC. Sarcoidosis epidemiology: recent estimates of incidence, prevalence and risk factors. Curr Opin Pulm Med. 2020 Sep;26(5):527–534. doi:10.1097/MCP.0000000000000715. - PMC - PubMed

LinkOut - more resources